Start › Niedrobnokomórkowy rak płuca › Tennessee › Memphis
Badania kliniczne dla Niedrobnokomórkowy rak płuca w mieście Memphis, TN
23 badań dla Niedrobnokomórkowy rak płuca szuka uczestników w ośrodkach w mieście Memphis i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekrutacjaFaza 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi dalej
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi dalej
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
RekrutacjaFaza 2
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi dalej
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi dalej
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekrutacjaFaza 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi dalej
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi dalej
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
RekrutacjaFaza 3
- Baptist Cancer Center, Memphis
- Baptist Clinical Research Institute, Memphis
- Baptist Cancer Center, Bartlett · 11 mi dalej
- i 3 więcej
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RekrutacjaFaza 3
- Regional One Health, Memphis
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
RekrutacjaFaza 2
- Research Site, Memphis
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
RekrutacjaFaza 2
- Baptist Clinical Research Institute, Memphis
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekrutacjaFaza 2/3
- West Cancer Center & Research Institute - East Campus, Germantown · 14 mi dalej
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
RekrutacjaFaza 2
- Baptist Clinical Research Institute, Memphis
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekrutacjaFaza 3
- Baptist Memorial Hospital-Memphis, Memphis
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekrutacjaFaza 3
- Baptist Cancer Center, Memphis
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RekrutacjaFaza 3
- Research Site, Memphis
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
RekrutacjaFaza 1
- The West Clinic, PLLC dba West Cancer Center, Germantown · 14 mi dalej
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RekrutacjaFaza 1/2
- Baptist Medical Center, Memphis
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
RekrutacjaFaza 2
- Baptist Cancer Center, Memphis
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi dalej
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi dalej
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekrutacjaFaza 1/2
- Baptist Memorial Hospital Baptist Cancer Center, Memphis
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi dalej
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi dalej
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2/3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi dalej
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi dalej
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi dalej
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi dalej
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekrutacjaBadanie obserwacyjne
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital for Women, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southaven · 11 mi dalej
- i 1 więcej
GEMINI-NSCLC: NSCLC Biomarker Study
RekrutacjaBadanie obserwacyjne
- Baptist Cancer Center, Memphis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekrutacjaBadanie obserwacyjne
- Massive Bio SYNERGY-AI site, Memphis
Badania dla Niedrobnokomórkowy rak płuca w innych miastach
- Houston, TX145 badań
- New York City, NY121 badań
- Arlington, VA104 badań
- Nashville, TN97 badań
- Boston, MA90 badań
- Los Angeles, CA87 badań
- St. Louis, MO73 badań
- Chicago, IL61 badań
- Baltimore, MD60 badań
- San Antonio, TX59 badań
- Columbus, OH57 badań
- Washington, DC55 badań
Inne badania w mieście Memphis
- Nowotwory (wszystkie typy)31 badań
- Rak piersi22 badań
- Rak płuc18 badań
- Anemia sierpowata18 badań
- Ostra białaczka limfoblastyczna16 badań
- Ostra białaczka szpikowa15 badań
- Niewydolność serca13 badań
- Mięsak tkanek miękkich11 badań
- Czerniak11 badań
- Rak prostaty11 badań
- Rak jelita grubego i odbytnicy11 badań
- Mięsak kościopochodny10 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.